Lv1
100 积分 2026-01-09 加入
Tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma (L-MIND): a multicentre, prospective, single-arm, phase 2 study
8天前
已完结
Belantamab mafodotin plus bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-7): updated overall survival analysis from a global, randomised, open-label, phase 3 trial
8天前
已完结
Teclistamab in Multiple Myeloma with One to Three Previous Lines of Therapy
9天前
已完结
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial
10天前
已完结
Factor B inhibitor iptacopan for the treatment of paroxysmal nocturnal hemoglobinuria
14天前
已完结
Insights on chronic immune thrombocytopenia pathogenesis: A bench to bedside update
19天前
已完结
Progress in the development of cytokine armoured CAR T cells
20天前
已完结
Addition of iptacopan, an oral factor B inhibitor, to eculizumab in patients with paroxysmal nocturnal haemoglobinuria and active haemolysis: an open-label, single-arm, phase 2, proof-of-concept trial
23天前
已完结
Clinical signs and symptoms associated with increased risk for thrombosis in patients with paroxysmal nocturnal hemoglobinuria from a Korean Registry
23天前
已完结
The incidence and prevalence of patients with paroxysmal nocturnal haemoglobinuria and aplastic anaemia PNH syndrome: A retrospective analysis of the UK's population-based haematological malignancy research network 2004-2018
1个月前
已完结
皖公网安备34019202002308
